

Funders
The Perinatal HIV Research Unit relies on pharmaceutical and donor funding for its research projects.Major funders:
- the National Institutes of Health
- United States Agency for International Development
- The Bill and Melinda Gates Foundation
- Agouron Pharmaceuticals (now Pfizer)
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Bristol-Myers Squibb Secure the Future
- Carnegie Foundation
- Comprehensive International Programme of Research on AIDS (CIPRA)
- Elizabeth Glaser Paediatric AIDS Foundation
- Gilead Sciences Inc.
- GlaxoSmithKline
- FSTI Le Fonds de Solidarité Thérapeutique International
- HIV Vaccine Trials Network (HVTN)
- International Aids Vaccine Initiative (IAVI)
- Ireland Development Corporation (no web site)
- Johns Hopkins University
- Merck
- National Institute of Allergy and Infectious Diseases (NIAID)
- New York Academy of Medicine
- OraSure
- Quality Assurance Project
- South African Department of Health
- South African Migration Project
- The Pediatric AIDS Clinical Trials Group (PACTG)
- United States National Institute of Mental Health
- United States National Institutes of Health
- University of California, San Francisco
- University of California, Los Angeles
